Advancing Cancer Treatment
Moultonboro, New Hampshire
B+Health Score
68B+
Financial Health Score
8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.
Good
💰
$2.1M
Total Revenue
📊
$1.3M
Total Expenses
🏦
$1.5M
Net Assets
📋
$30K
Total Liabilities
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Revenue Growth
-31.3%
Year-over-year change (2022 → 2023)
Net Margin
+39.1%
Revenue minus expenses as % of revenue
Working Capital Ratio
1.15
Net assets divided by total expenses
Liabilities-to-Assets
2.0%
Total liabilities as % of total assets
Filing History
5 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $2,068,192↓31% | $1,260,009↓59% | $1,484,614↑117% | — |
| 2022 | $3,010,183↑101% | $3,103,502↑279% | $683,975↓42% | — |
| 2021 | $1,500,077↓6% | $819,640↓30% | $1,177,066↑137% | — |
| 2020 | $1,600,117↑165% | $1,173,683↑120% | $496,629↑607% | — |
| 2019 | $604,430 | $534,237 | $70,195 | — |
Frequently Asked Questions
What does Advancing Cancer Treatment do?▼
Advancing Cancer Treatment is a diseases, disorders & medical disciplines nonprofit organization based in New Hampshire. It is classified under NTEE code G12 and is registered as a 501(c) tax-exempt organization with the IRS.
Is Advancing Cancer Treatment financially healthy?▼
Financial health scoring requires Form 990 filing data. Check back as we process more filings for Advancing Cancer Treatment.
How much revenue does Advancing Cancer Treatment generate?▼
Advancing Cancer Treatment reports $43K in annual revenue and holds $714K in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Diseases, Disorders & Medical Disciplines category, or browse all nonprofits in New Hampshire.